# Progress Note 05 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ulysses S. Grant (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI002-SYN
- Date: 2026-10-22
- Fictional facility: St. Posthumous Health Center
- Fictional author: Corinne Batiste, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Primary care review three weeks after chemoradiation. **S**

## History of present illness

Mr. Grant returns three weeks after finishing chemoradiation, directed by the head and neck oncology team, for p16-negative squamous cell carcinoma of the right tonsillar pillar. His throat pain has eased to 3 of 10. He takes the acetaminophen solution once or twice a day and rarely needs the lidocaine rinse. His mouth is dry and food tastes muted, so he sips water with every mouthful. He eats soft foods with two supplement drinks a day and did not need a feeding tube. He weighs 71.0 kg, 7 kg below his weight at intake. He has smoked no cigars since mid-July and continues varenicline 1 mg twice daily without side effects. His energy is slowly returning and he writes for two to three hours a day. He has had no fever, bleeding, choking, or new lumps in the neck, and no change in his hearing. He uses fluoride gel in trays each night, as the dentist advised before radiation. **S**

| Element | Detail |
|---|---|
| Treatment | Chemoradiation completed three weeks ago |
| Pain | 3 of 10; acetaminophen once or twice a day; lidocaine rinse rarely |
| Late effects | Dry mouth and muted taste; no choking |
| Weight and nutrition | 71.0 kg, 9 percent below intake; no feeding tube needed |
| Tobacco | No cigars since mid-July; varenicline continued |
| Function | Energy returning; writing two to three hours a day |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue, improving; no fever or night sweats |
| Ears, nose, mouth, and throat | Positive | Dry mouth, muted taste, and throat pain 3 of 10; no hearing change or ear pain |
| Respiratory | Negative | No cough, choking with liquids, or breathlessness |
| Gastrointestinal | Negative | No nausea or vomiting; bowels regular |
| Integumentary | Positive | Darkened, dry skin on the neck from radiation, healing |
| Hematologic | Negative | No bruising or bleeding |
| Psychiatric | Negative | Mood steady; PHQ-2 score 1 |

7 systems reviewed. **S**

## Current medications

- Varenicline 1 mg oral tablet, one tablet twice daily **S**
- Acetaminophen 160 mg/5 mL oral solution, 20 mL (640 mg) every 6 hours as needed for throat pain **S**
- Lidocaine viscous 2% solution, 15 mL swish and spit up to every 3 hours as needed for throat pain **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/72 mmHg; pulse 84 bpm; respirations 16/min; temperature 36.9 °C; oxygen saturation 97% on room air; weight 71 kg; BMI 23.7 kg/m². All vital signs are synthetic.

Hemoglobin: 11.9 g/dL (low); White blood cell count: 3.6 10*3/uL (low); Platelet count: 168 10*3/uL; Sodium: 136 mmol/L; Potassium: 4 mmol/L; Creatinine: 1.12 mg/dL; eGFR: 74 mL/min/1.73 m²; Glucose: 94 mg/dL; Albumin: 3.3 g/dL (low); Throat pain (0-10): 3; PHQ-2: 1. All results are synthetic.

## Change since baseline

- Hemoglobin: 14.1 g/dL at baseline, 11.9 g/dL (low) at this visit **S**
- White blood cell count: 8.4 10*3/uL at baseline, 3.6 10*3/uL (low) at this visit **S**
- Platelet count: 262 10*3/uL at baseline, 168 10*3/uL at this visit **S**
- Sodium: 139 mmol/L at baseline, 136 mmol/L at this visit **S**
- Potassium: 4.3 mmol/L at baseline, 4 mmol/L at this visit **S**
- Creatinine: 0.98 mg/dL at baseline, 1.12 mg/dL at this visit **S**
- eGFR: 87 mL/min/1.73 m² at baseline, 74 mL/min/1.73 m² at this visit **S**
- Glucose: 92 mg/dL at baseline, 94 mg/dL at this visit **S**
- Albumin: 3.9 g/dL at baseline, 3.3 g/dL (low) at this visit **S**
- Throat pain (0-10): 5 at baseline, 3 at this visit **S**
- PHQ-2: 1 at baseline, 1 at this visit **S**

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**

## Physical examination

| System | Finding |
|---|---|
| General | Thinner, alert, and in good spirits |
| Oropharynx | Dry mucosa; the treated right tonsillar area is healing, with no ulcer or visible mass |
| Neck | Healing radiation skin changes; firm tissue on the right with no discrete node |
| Lungs | Clear |
| Heart | Regular rhythm; no murmur |

All examination findings are synthetic. **S**

## Assessment and plan

1. **p16-negative squamous cell carcinoma of the right tonsillar pillar, three weeks after chemoradiation** (C09.1). No clinical sign of persistent disease; response is judged on PET/CT at least 12 weeks after treatment. Mild anemia (hemoglobin 11.9) and a low white count (3.6) are expected after treatment. Creatinine 1.12 (eGFR 74, down from 87) and albumin 3.3 g/dL. **S**
   - Head and neck oncology follow-up with examination and laryngoscopy every one to three months in the first year.
   - Post-treatment PET/CT about 12 weeks after treatment, arranged by the head and neck team.
   - Repeat CBC and basic metabolic panel in four to six weeks; drink about 2 liters a day.
   - TSH every six to twelve months after neck radiation, starting about six months after treatment.
   - Call the same day for a temperature of 38 °C or higher while the white count recovers.
2. **Nicotine dependence, cigars, in early remission** (F17.290). About fourteen weeks without cigars on varenicline, which he tolerates. **S**
   - Continue varenicline 1 mg twice daily to complete a second 12-week course, about 24 weeks in all, to prevent relapse.
   - Counseling today: continued abstinence lowers the risk of a second tobacco-related cancer.
3. **Oropharyngeal dysphagia, with dry mouth and taste change after radiation** (R13.12). Throat pain 3 of 10; swallowing soft foods and liquids without choking. **S**
   - Speech-language pathology swallowing review after treatment.
   - Saliva substitute, frequent sips of water, and sugar-free gum or lozenges.
   - Continue nightly fluoride trays; dental review every six months.
4. **Unintended weight loss** (R63.4). Weight 71.0 kg, 9 percent below the 78 kg baseline, so the goal of losing less than 10 percent was met; albumin 3.3 g/dL. **S**
   - Dietitian follow-up to regain weight.
   - Weight at every visit.
5. **Immunizations**. Influenza vaccine due for the season; PCV20 given before treatment. **S**
   - Influenza vaccine given today.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | CBC, basic metabolic panel, and albumin | Before and after treatment | Completed today | Hemoglobin 11.9 and white count 3.6, both low after treatment; platelets 168; sodium 136, potassium 4.0, creatinine 1.12, eGFR 74, glucose 94; albumin 3.3, low |
| Laboratory | Repeat CBC and basic metabolic panel | Until counts and kidney function recover | Due | In four to six weeks |
| Laboratory | TSH | Every 6 to 12 months after neck radiation | Due | Baseline 1.8 mIU/L; first check about six months after treatment |
| Examination | History and head and neck examination | Every 1 to 3 months in the first year after treatment | Completed today | No ulcer, mass, or discrete neck node; laryngoscopy at the head and neck oncology follow-up |
| Referral | Head and neck oncology follow-up with laryngoscopy | Every 1 to 3 months in the first year after treatment | Due | First post-treatment review with the head and neck team in the coming weeks |
| Imaging | Post-treatment PET/CT | At least 12 weeks after treatment, within 6 months | Due | About nine weeks from now, arranged by the head and neck team |
| Imaging | Lung cancer screening with low-dose CT | Annually for eligible current and former smokers | Not indicated | Screening eligibility is defined by cigarette pack-years, and his tobacco use was cigars; the post-treatment PET/CT includes the chest |
| Examination | Weight | Every visit | Completed today | 71.0 kg, 9 percent below baseline; goal of less than 10 percent loss met |
| Survey | Throat pain score (0-10) | Every visit | Completed today | 3 of 10 |
| Survey | Depression screen (PHQ-2) | Every primary care visit after the diagnosis | Completed today | Score 1 |
| Survey | PHQ-9 after a PHQ-2 score of 2 or more | Whenever the PHQ-2 is 2 or more | Deferred | The PHQ-2 of 2 at the pre-treatment visit was not followed by a PHQ-9, a deviation from the protocol. Today's PHQ-2 is 1 and he reports a steady mood, so no harm is evident; a PHQ-9 will follow any PHQ-2 of 2 or more |
| Referral | Speech-language pathology swallowing review | After treatment and as needed | Referred | Referred for a post-treatment swallowing assessment |
| Referral | Dietitian follow-up | During recovery | Referred | To help him regain weight; albumin 3.3 |
| Referral | Dental review with daily fluoride | Every 6 months after neck radiation | Up to date | Dental evaluation done before radiation; fluoride trays nightly |
| Examination | Hearing and ear symptoms | Each follow-up visit | Completed today | No hearing change or ear pain |
| Self-management | Tobacco use status and cessation counseling | Every visit | Completed today | No cigars for about fourteen weeks; relapse-prevention counseling given |
| Medication safety | Varenicline tolerance: nausea, sleep, mood, and behavior | Each visit during treatment | Completed today | No side effects; continued to complete about 24 weeks in all |
| Medication safety | Influenza vaccine | Every season | Completed today | Given today |

## Goal progress

- Tissue diagnosis within two weeks of the first visit. Outcome by 2026-07-21: Biopsy at the otolaryngology visit two weeks after presentation. **S**
- Stop all tobacco use before treatment begins. Outcome by 2026-08-04: No cigars since mid-July 2026; varenicline continued. **S**
- Limit weight loss to less than 10% of baseline weight through treatment. Outcome by 2026-10-22: Weight 71.0 kg, 9% below the 78.0 kg baseline. **S**
- Keep throat pain at 4 or below on the 0-10 scale most days. Outcome by 2026-10-22: Pain score 3 of 10. **S**

## Guideline basis

- NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025 (2025), National Comprehensive Cancer Network
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, depression and hypothyroidism monographs (2026), Aether Forge
- American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016), American Cancer Society

## Follow-up

- Head and neck oncology follow-up in the coming weeks and post-treatment PET/CT about 12 weeks after treatment. Primary care visit in four to six weeks with a CBC and basic metabolic panel. **S**

